Cargando…

Does the preoperative platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio predict morbidity after gastrectomy for gastric cancer?

BACKGROUND: Gastric cancer is the 2nd most common cause of cancer-related deaths, and the morbidity rate after surgery is reported to be as high as 46%. The estimation of possible complications, morbidity, and mortality and the ability to specify patients at high risk have become substantial for an...

Descripción completa

Detalles Bibliográficos
Autores principales: Mungan, İbrahim, Dicle, Çilem Bayındır, Bektaş, Şerife, Sarı, Sema, Yamanyar, Serdar, Çavuş, Mine, Turan, Sema, Bostancı, Erdal Birol
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7049207/
https://www.ncbi.nlm.nih.gov/pubmed/32111261
http://dx.doi.org/10.1186/s40779-020-00234-y
_version_ 1783502392971493376
author Mungan, İbrahim
Dicle, Çilem Bayındır
Bektaş, Şerife
Sarı, Sema
Yamanyar, Serdar
Çavuş, Mine
Turan, Sema
Bostancı, Erdal Birol
author_facet Mungan, İbrahim
Dicle, Çilem Bayındır
Bektaş, Şerife
Sarı, Sema
Yamanyar, Serdar
Çavuş, Mine
Turan, Sema
Bostancı, Erdal Birol
author_sort Mungan, İbrahim
collection PubMed
description BACKGROUND: Gastric cancer is the 2nd most common cause of cancer-related deaths, and the morbidity rate after surgery is reported to be as high as 46%. The estimation of possible complications, morbidity, and mortality and the ability to specify patients at high risk have become substantial for an intimate follow-up and for proper management in the intensive care unit. This study aimed to determine the prognostic value of the preoperative platelet-to-lymphocyte ratio (PLR) and neutrophil-to-lymphocyte ratio (NLR) and their relations with clinical outcomes and complications after gastrectomy for gastric cancer. METHODS: This single-center, retrospective cohort study evaluated the data of 292 patients who underwent gastrectomy with curative intent between January 2015 and June 2018 in a tertiary state hospital in Ankara, Turkey. A receiver operating characteristic curve was generated to evaluate the ability of laboratory values to predict clinically relevant postoperative complications. The area under the curve was computed to compare the predictive power of the NLR and PLR. Then, the cutoff points were selected as the stratifying values for the PLR and NLR. RESULTS: The area under the curve values of the PLR (0.60, 95% CI 0.542–0.657) and NLR (0.556, 95% CI 0.497–0.614) were larger than those of the other preoperative laboratory values. For the PLR, the diagnostic sensitivity and specificity were 50.00 and 72.22%, respectively, whereas for the NLR, the diagnostic sensitivity and specificity were 37.50 and 80.16%, respectively. The PLR was related to morbidity, whereas the relation of the NLR with mortality was more prominent. This study demonstrated that the PLR and NLR may predict mortality and morbidity via the Clavien-Dindo classification in gastric cancer patients. The variable was grade ≥ 3 in the Clavien-Dindo classification, including complications requiring surgical or endoscopic interventions, life-threatening complications, and death. Both the PLR and NLR differed significantly according to Clavien-Dindo grade ≥ 3. In this analysis, the PLR was related to morbidity, while the NLR relation with mortality was more intense. CONCLUSION: Based on the results of the study, the PLR and NLR could be used as independent predictive factors for mortality and morbidity in patients with gastric cancer.
format Online
Article
Text
id pubmed-7049207
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-70492072020-03-10 Does the preoperative platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio predict morbidity after gastrectomy for gastric cancer? Mungan, İbrahim Dicle, Çilem Bayındır Bektaş, Şerife Sarı, Sema Yamanyar, Serdar Çavuş, Mine Turan, Sema Bostancı, Erdal Birol Mil Med Res Research BACKGROUND: Gastric cancer is the 2nd most common cause of cancer-related deaths, and the morbidity rate after surgery is reported to be as high as 46%. The estimation of possible complications, morbidity, and mortality and the ability to specify patients at high risk have become substantial for an intimate follow-up and for proper management in the intensive care unit. This study aimed to determine the prognostic value of the preoperative platelet-to-lymphocyte ratio (PLR) and neutrophil-to-lymphocyte ratio (NLR) and their relations with clinical outcomes and complications after gastrectomy for gastric cancer. METHODS: This single-center, retrospective cohort study evaluated the data of 292 patients who underwent gastrectomy with curative intent between January 2015 and June 2018 in a tertiary state hospital in Ankara, Turkey. A receiver operating characteristic curve was generated to evaluate the ability of laboratory values to predict clinically relevant postoperative complications. The area under the curve was computed to compare the predictive power of the NLR and PLR. Then, the cutoff points were selected as the stratifying values for the PLR and NLR. RESULTS: The area under the curve values of the PLR (0.60, 95% CI 0.542–0.657) and NLR (0.556, 95% CI 0.497–0.614) were larger than those of the other preoperative laboratory values. For the PLR, the diagnostic sensitivity and specificity were 50.00 and 72.22%, respectively, whereas for the NLR, the diagnostic sensitivity and specificity were 37.50 and 80.16%, respectively. The PLR was related to morbidity, whereas the relation of the NLR with mortality was more prominent. This study demonstrated that the PLR and NLR may predict mortality and morbidity via the Clavien-Dindo classification in gastric cancer patients. The variable was grade ≥ 3 in the Clavien-Dindo classification, including complications requiring surgical or endoscopic interventions, life-threatening complications, and death. Both the PLR and NLR differed significantly according to Clavien-Dindo grade ≥ 3. In this analysis, the PLR was related to morbidity, while the NLR relation with mortality was more intense. CONCLUSION: Based on the results of the study, the PLR and NLR could be used as independent predictive factors for mortality and morbidity in patients with gastric cancer. BioMed Central 2020-02-29 /pmc/articles/PMC7049207/ /pubmed/32111261 http://dx.doi.org/10.1186/s40779-020-00234-y Text en © The Author(s) 2020 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Mungan, İbrahim
Dicle, Çilem Bayındır
Bektaş, Şerife
Sarı, Sema
Yamanyar, Serdar
Çavuş, Mine
Turan, Sema
Bostancı, Erdal Birol
Does the preoperative platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio predict morbidity after gastrectomy for gastric cancer?
title Does the preoperative platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio predict morbidity after gastrectomy for gastric cancer?
title_full Does the preoperative platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio predict morbidity after gastrectomy for gastric cancer?
title_fullStr Does the preoperative platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio predict morbidity after gastrectomy for gastric cancer?
title_full_unstemmed Does the preoperative platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio predict morbidity after gastrectomy for gastric cancer?
title_short Does the preoperative platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio predict morbidity after gastrectomy for gastric cancer?
title_sort does the preoperative platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio predict morbidity after gastrectomy for gastric cancer?
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7049207/
https://www.ncbi.nlm.nih.gov/pubmed/32111261
http://dx.doi.org/10.1186/s40779-020-00234-y
work_keys_str_mv AT munganibrahim doesthepreoperativeplatelettolymphocyteratioandneutrophiltolymphocyteratiopredictmorbidityaftergastrectomyforgastriccancer
AT diclecilembayındır doesthepreoperativeplatelettolymphocyteratioandneutrophiltolymphocyteratiopredictmorbidityaftergastrectomyforgastriccancer
AT bektasserife doesthepreoperativeplatelettolymphocyteratioandneutrophiltolymphocyteratiopredictmorbidityaftergastrectomyforgastriccancer
AT sarısema doesthepreoperativeplatelettolymphocyteratioandneutrophiltolymphocyteratiopredictmorbidityaftergastrectomyforgastriccancer
AT yamanyarserdar doesthepreoperativeplatelettolymphocyteratioandneutrophiltolymphocyteratiopredictmorbidityaftergastrectomyforgastriccancer
AT cavusmine doesthepreoperativeplatelettolymphocyteratioandneutrophiltolymphocyteratiopredictmorbidityaftergastrectomyforgastriccancer
AT turansema doesthepreoperativeplatelettolymphocyteratioandneutrophiltolymphocyteratiopredictmorbidityaftergastrectomyforgastriccancer
AT bostancıerdalbirol doesthepreoperativeplatelettolymphocyteratioandneutrophiltolymphocyteratiopredictmorbidityaftergastrectomyforgastriccancer